COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug Application for DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia

23/04/2018 - 14:30

NOVATO, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Vystar Acquires Assets of NHS Holdings

23/04/2018 - 14:30

Purchases Assets of NHS at a 70% Discount From $4.6 Million Valuation Transitions Vystar Focus from Rubber Commodities to Higher Revenue, Higher Margin Product Sales WORCESTER, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- [...]

Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Devel-opments on May 3, 2018

23/04/2018 - 14:30

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Acology Purchases Entire MedTainer Intellectual Property Portfolio

23/04/2018 - 14:30

Purchase Provides Catalysts to Rapid Global Expansion CORONA, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC:ACOL) is pleased to announce the purchase of the entire intellectual property portfolio for [...]

Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

23/04/2018 - 14:30

MINNEAPOLIS, April 23, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]

Alder BioPharmaceuticals® Appoints Eric Carter, Ph.D., M.D., as Interim Chief Medical Officer

23/04/2018 - 14:30

BOTHELL, Wash., April 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc., (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

23/04/2018 - 14:30

WESTMINSTER, Colo., April 23, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]

HempAmericana Announces Augusta CBD Oil Facility Now “Open for Business”

23/04/2018 - 14:30

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is thrilled to announce that the new Vitalis R-200 high-capacity supercritical CO2 CBD Oil [...]

Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting

23/04/2018 - 14:30

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, [...]

Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales and Marketing Function

23/04/2018 - 14:30

TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility

23/04/2018 - 14:20

EAST RUTHERFORD, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

23/04/2018 - 14:15

First Gene Therapy Using AAV Approach Granted Regenerative Medicine Advanced Therapy Designation NEW YORK and CLEVELAND, April 23, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical- [...]

Achaogen Highlights Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

23/04/2018 - 14:01

-- Study findings support the potential for plazomicin to address difficult-to-treat infections, including those caused by carbapenem-resistant Enterobacteriaceae -- SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE [...]

Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin

23/04/2018 - 14:00

BEVERLY, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a drug supply contract [...]

Prothena Discontinues Development of NEOD001 for AL Amyloidosis

23/04/2018 - 14:00

Phase 2b PRONTO study did not meet its primary or secondary endpoints Phase 3 VITAL Amyloidosis Study being discontinued based on futility analysis Investor conference call and webcast today at 8:30 AM ET DUBLIN, [...]

Beacon Health Selects R1 RCM for Expanded Revenue Cycle Services

23/04/2018 - 14:00

CHICAGO, April 23, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced that Beacon Health based [...]

Sorrento Therapeutics CEO Dr. Henry Ji Invited to the Fourth International Vatican Conference on “Unite to Cure”

23/04/2018 - 14:00

SAN DIEGO, April 23, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, has been invited to participate as an expert panelist at the [...]

Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations

23/04/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced the appointment of Brad Kreger as Senior Vice President, Global Operations. In this role, Kreger leads [...]

Melinta Therapeutics Presents Results from VABOMERE TANGO II Trial at ECCMID 2018, Highlighting Outcomes in Vulnerable Patient Populations

23/04/2018 - 14:00

NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]